Big announcement
1. Huazhu Group-S: Revenue for the third quarter increased 53.6% year on year to 6.3 billion yuan, and net profit from the mother's net profit turned a loss year over year into a profit
$HWORLD-S (01179.HK)$Releasing results for the three months ended September 30, 2023, the Group achieved total revenue of 6.288 billion yuan (RMB, same below), an increase of 53.63% over the previous year and an increase of 13.71% over the previous year; net profit attributable to Huazhu Group Limited was 1,337 billion yuan, compared with a net loss of 717 million yuan for the same period last year.
2. China Jinmao: Plans to spend 1,881.9 billion yuan to acquire 51% of Xinmao Real Estate's shares to cooperate in the development of the Suzhou High-tech Zone
$CHINA JINMAO (00817.HK)$It was announced that on November 24, 2023, Ningbo Ningxing, an indirect subsidiary of the Company, signed a cooperation agreement with Nanjing Yaofang and Xinmao Real Estate to cooperate in the development of the target plot. According to the cooperation agreement, Ningbo Ningxing will acquire 51% of Xinmao Real Estate's shares from Nanjing Yaofang and pay Xinmao Real Estate a registered capital of RMB 1,881.9 billion to Xinmao Real Estate.
3. Colon Botai Bio-B: The main product A400 (EP0031) was granted orphan drug qualification by the US Food and Drug Administration
$SKB BIO-B (06990.HK)$An announcement was issued that the company's main product, A400 (rearrangement in the transfection process (RET) small molecule kinase inhibitor project, also known as KL590586 or EP0031, has obtained orphan drug qualification from the US Food and Drug Administration (FDA) for the treatment of RET fusion-positive solid tumors.
4. Anta Sports: Proposed share purchase under a share incentive plan, with a total investment of not more than HK$1.2 billion
$ANTA SPORTS (02020.HK)$An announcement was issued. In order to cooperate with and support the Group's development strategy, the company intends to invest a total of no more than HK$1.2 billion within the next three years for trustees to purchase and hold shares in accordance with the “2018 Stock Award Plan (Revised Edition 2023)” for the purpose of awarding employee share rewards.
Important matters
$Shenghui Cleanness Group Holdings Limited (810378.HK)$Starting November 27, the IPO price is HK$0.32-0.40 per share
$K cash (810474.HK)$Starting November 27, the IPO price is HK$1.64-1.96 per share
$DEKON FOOD AND AGRICULTURE GROUP (810254.HK)$Starting November 27, the prospectus price is HK$30.35-36.95 per share
$Sino-Synergy Hydrogen Energy Technology(Jiaxing)Co., Ltd (810449.HK)$Starting November 27, the IPO price is HK$19.35-21.35 per share
$DATANG RENEW (01798.HK)$It is proposed to introduce Datang as a direct shareholder of Datang Financial Leasing to improve the capital structure of Datang Financial Leasing
$CHINA UNICOM (00762.HK)$: Director and President Chen Zhongyue has become the chairman of China Unicom Group, the final parent company
$GEELY AUTO (00175.HK)$: Krypton publicly submitted its updated registration statement to the US Securities and Exchange
Earnings Report
$TONGDAO LIEPIN (06100.HK)$: Revenue for the nine months ended September 30, 2023 was 1,652 million yuan, and net profit was 40.293 million yuan
$PERFECT MEDICAL (01830.HK)$: Revenue for the six months ended 30 September 2023 was HK$718 million, up 7.5% year on year
Pharmaceutical Innovation
$HENLIUS (02696.HK)$: A phase 1 clinical study of injectable HLX43 (targeted PD-L1 antibody - novel DNA topoisomerase I inhibitor conjugate drug) in patients with advanced/metastatic solid tumors completed the first patient administration in China
$IMMUNOTECH-B (06978.HK)$: Notice of acceptance of new drug research applications for AT19 injections
Acquisition and sale
$DATANG POWER (00991.HK)$: Datang Group plans to invest 30% of the shares of Shanghai Datang Leasing Company at a price of 538 million yuan to subscribe Datang Leasing Company to increase the registered capital of all Datang Leasing companies
$CIL GROUP (01719.HK)$: Wuhan Zhongji plans to sell 60% of Zhongji's shares in Zhongxiang City for 69.576,900 yuan
Equity incentives
$ANTA SPORTS (02020.HK)$The total investment for the proposed purchase of shares under the share incentive scheme does not exceed HK$1.2 billion
$Baozun (BZUN.US)$: Granting 77,019 restricted share unit awards
Repurchase cancellation
$TENCENT (00700.HK)$On November 24, 1.24 million shares were repurchased at a cost of HK$402 million
$HSBC HOLDINGS (00005.HK)$Repurchase of 2,9976 million shares at a cost of HK$178 million on November 23
$AIA (01299.HK)$Repurchase of 1,8772 million shares at a cost of HK$135 million on November 24
$YUM CHINA (09987.HK)$On November 24, it spent $13.9934 million to repurchase 310,900 shares
$SINOPEC CORP (00386.HK)$Repurchase of 8.716 million shares at a cost of HK$35.9256 million on November 24
$JBM HEALTHCARE (02161.HK)$Repurchase of 17.6 million shares at a cost of HK$20.3 million on November 24
$COSCO SHIP HOLD (01919.HK)$On November 24, 2.39 million shares were repurchased at a cost of HK$17.367 million
$JIUMAOJIU (09922.HK)$Repurchase of 1.2 million shares at a cost of HK$10.74 million on November 24
$CONCH CEMENT (00914.HK)$On November 24, it spent 9.9944 million yuan to buy back 420,000 A-shares
$CONCORD NE (00182.HK)$Repurchase of 9.21 million shares at a cost of HK$6.17 million on November 24
$HAIER SMARTHOME (06690.HK)$On November 24, it spent 5.84 million yuan to buy back 260,000 A-shares
edit/ruby